Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19.
Efimov SV, Matsiyeuskaya NV, Boytsova OV, Akhieva LY, Kuntsevich EV, Troshina AA, Kvasova EI, Tikhonov AA, Khomyakova NF, Harrison F, Rossi JF, Hardman TC.
Efimov SV, et al. Among authors: tikhonov aa.
Drugs Context. 2022 Mar 3;11:2022-1-1. doi: 10.7573/dic.2022-1-1. eCollection 2022.
Drugs Context. 2022.
PMID: 35310299
Free PMC article.